The safety of induced ventricular fibrillation during cardiopulmonary bypass in nonhypertrophied hearts.
D000200:Action Potentials; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002315:Cardiopulmonary Bypass; D003326:Coronary Circulation; D003327:Coronary Disease / Q000209:etiology* / Q000503:physiopathology; D003402:Creatine Kinase / Q000097:blood / Q000378:metabolism; D004285:Dogs; D004558:Electric Stimulation; D006352:Heart Ventricles / Q000473:pathology; D007527:Isoenzymes / Q000097:blood; D014693:Ventricular Fibrillation / Q000150:complications* / Q000209:etiology / Q000503:physiopathology
D007527:Isoenzymes; D000255:Adenosine Triphosphate; D003402:Creatine Kinase